AIG
KNSA icon

American International Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

American International Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,664
Closed -$309K – 1421
2024
Q1 		$309K Buy
15,664
+69
+0.4% +$1.35K ﹤0.01% 1901
2023
Q4 		$274K Sell
15,595
-63
-0.4% -$1.03K ﹤0.01% 2005
2023
Q3 		$272K Buy
15,658
+557
+4% +$9.38K ﹤0.01% 1952
2023
Q2 		$213K Buy
15,101
+66
+0.4% +$883 ﹤0.01% 2123
2023
Q1 		$162K Buy
15,035
+299
+2% +$3.94K ﹤0.01% 2231
2022
Q4 		$221K Sell
14,736
-54
-0.4% -$786 ﹤0.01% 2086
2022
Q3 		$190K Buy
14,790
+209
+1% +$2.38K ﹤0.01% 2183
2022
Q2 		$141K Buy
14,581
+102
+0.7% +$952 ﹤0.01% 2394
2022
Q1 		$144K Sell
14,479
-1,020
-7% -$10.8K ﹤0.01% 2432
2021
Q4 		$182K Sell
15,499
-463
-3% -$5.69K ﹤0.01% 2429
2021
Q3 		$182K Sell
15,962
-379
-2% -$4.94K ﹤0.01% 2485
2021
Q2 		$228K Buy
16,341
+761
+5% +$11.6K ﹤0.01% 2426
2021
Q1 		$288K Buy
15,580
+40
+0.3% +$818 ﹤0.01% 2158
2020
Q4 		$275K Sell
15,540
-444
-3% -$7.8K ﹤0.01% 2100
2020
Q3 		$245K Buy
15,984
+4,355
+37% +$81.8K ﹤0.01% 2013
2020
Q2 		$296K Buy
11,629
+3,370
+41% +$70.4K ﹤0.01% 1883
2020
Q1 		$128K Sell
8,259
-478
-5% -$7.48K ﹤0.01% 2167
2019
Q4 		$97K Sell
8,737
-73
-0.8% -$634 ﹤0.01% 2641
2019
Q3 		$75K Sell
8,810
-61
-0.7% -$674 ﹤0.01% 2745
2019
Q2 		$120K Buy
8,871
+1,311
+17% +$20.3K ﹤0.01% 2568
2019
Q1 		$137K Buy
7,560
+3,288
+77% +$63.5K ﹤0.01% 2430
2018
Q4 		$120K Sell
4,272
-32
-0.7% -$668 ﹤0.01% 2499
2018
Q3 		$110K Buy
+4,304
New +$83.7K ﹤0.01% 2783

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's KNSA Position: Q2 2024 in Review

American International Group sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2024, closing a stake of 15,664 shares — an estimated $309K sold.

American International Group first reported a position in KNSA in Q3 2018 and held it in 23 quarters. The position peaked at $309K in Q1 2024. 133 funds tracked by Wall St. Rank hold KNSA as of Q2 2024.

  • American International Group reported no remaining Kiniksa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 15,664 Kiniksa Pharmaceuticals shares in Q2 2024, an estimated $309K.
  • American International Group first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and held it in 23 quarters.
  • American International Group's Kiniksa Pharmaceuticals position peaked at $309K in Q1 2024.
  • 133 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.